ARYx Therapeutics, Inc.: Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association
11/18/2009 9:38:36 AM
More...
|
ARYx Therapeutics, Inc. Reports Third Quarter 2009 Results
11/12/2009 8:41:41 AM
More...
|
ARYx Therapeutics, Inc. Schedules Third Quarter 2009 Results Conference Call
11/5/2009 9:18:31 AM
More...
|
ARYx Therapeutics, Inc. to Present at the Oppenheimer Annual Healthcare Conference
10/30/2009 8:54:01 AM
More...
|
ARYx Therapeutics, Inc. Aligns Operations to Development Activities; Company to Cut Staff
10/29/2009 6:13:32 AM
More...
|
ARYx Therapeutics, Inc. Secures $35 Million Committed Equity Financing Facility
10/7/2009 6:26:39 AM
More...
|
ARYx Therapeutics, Inc. to Present at the Morgan Stanley Global Healthcare Conference
9/9/2009 9:48:11 AM
More...
|
ARYx Therapeutics, Inc. Reports Second Quarter 2009 Results
8/13/2009 8:57:13 AM
More...
|
ARYx Therapeutics, Inc. Schedules Second Quarter 2009 Results Conference Call
8/5/2009 9:42:01 AM
More...
|
ARYx Therapeutics, Inc. Blood Clot Treatment Fails in Study
7/8/2009 7:29:51 AM
More...
|
|